Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.01 Billion CNY | -6.03% |
| 2022 | 4.27 Billion CNY | 6.82% |
| 2021 | 4 Billion CNY | 5.95% |
| 2020 | 3.77 Billion CNY | 9.12% |
| 2019 | 3.46 Billion CNY | 4.03% |
| 2018 | 3.32 Billion CNY | 18.27% |
| 2017 | 2.81 Billion CNY | 65.9% |
| 2016 | 1.69 Billion CNY | 12.88% |
| 2015 | 1.5 Billion CNY | 42.46% |
| 2014 | 1.05 Billion CNY | 833.63% |
| 2013 | 113 Million CNY | 1030.0% |
| 2012 | 10 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 60.6 Million CNY | -3.81% |
| 2008 | 63 Million CNY | -26.32% |
| 2007 | 85.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3.31 Billion CNY | -17.6% |
| 2024 Q3 | 2.79 Billion CNY | -3.18% |
| 2024 Q2 | 3.05 Billion CNY | -7.67% |
| 2023 Q4 | 4.01 Billion CNY | 14.09% |
| 2023 Q2 | 4.05 Billion CNY | -4.88% |
| 2023 FY | 4.01 Billion CNY | -6.03% |
| 2023 Q3 | 3.52 Billion CNY | -13.03% |
| 2023 Q1 | 4.25 Billion CNY | -0.44% |
| 2022 Q2 | 4.51 Billion CNY | 5.89% |
| 2022 Q3 | 4.3 Billion CNY | -4.54% |
| 2022 FY | 4.27 Billion CNY | 6.82% |
| 2022 Q4 | 4.27 Billion CNY | -0.73% |
| 2022 Q1 | 4.26 Billion CNY | 6.45% |
| 2021 Q3 | 3.71 Billion CNY | 3.35% |
| 2021 Q4 | 4 Billion CNY | 7.87% |
| 2021 Q1 | 3.39 Billion CNY | -10.09% |
| 2021 FY | 4 Billion CNY | 5.95% |
| 2021 Q2 | 3.59 Billion CNY | 5.7% |
| 2020 Q3 | 3.68 Billion CNY | 3.66% |
| 2020 Q1 | 3.65 Billion CNY | 5.59% |
| 2020 Q4 | 3.77 Billion CNY | 2.58% |
| 2020 Q2 | 3.55 Billion CNY | -2.8% |
| 2020 FY | 3.77 Billion CNY | 9.12% |
| 2019 Q3 | 3.29 Billion CNY | -9.98% |
| 2019 Q1 | 3.84 Billion CNY | 15.59% |
| 2019 Q4 | 3.46 Billion CNY | 5.25% |
| 2019 FY | 3.46 Billion CNY | 4.03% |
| 2019 Q2 | 3.65 Billion CNY | -5.02% |
| 2018 Q2 | 3.57 Billion CNY | 7.91% |
| 2018 Q1 | 3.31 Billion CNY | 17.62% |
| 2018 FY | 3.32 Billion CNY | 18.27% |
| 2018 Q3 | 3.67 Billion CNY | 2.86% |
| 2018 Q4 | 3.32 Billion CNY | -9.41% |
| 2017 Q2 | 2.11 Billion CNY | 1.79% |
| 2017 FY | 2.81 Billion CNY | 65.9% |
| 2017 Q4 | 2.81 Billion CNY | 32.77% |
| 2017 Q3 | 2.12 Billion CNY | 0.25% |
| 2017 Q1 | 2.07 Billion CNY | 22.46% |
| 2016 Q4 | 1.69 Billion CNY | 1.32% |
| 2016 Q1 | 1.43 Billion CNY | -4.52% |
| 2016 Q2 | 1.7 Billion CNY | 18.75% |
| 2016 FY | 1.69 Billion CNY | 12.88% |
| 2016 Q3 | 1.67 Billion CNY | -1.73% |
| 2015 Q3 | 1.74 Billion CNY | 19.75% |
| 2015 FY | 1.5 Billion CNY | 42.46% |
| 2015 Q1 | 1.13 Billion CNY | 7.11% |
| 2015 Q4 | 1.5 Billion CNY | -13.62% |
| 2015 Q2 | 1.45 Billion CNY | 28.59% |
| 2014 Q1 | 112.94 Million CNY | -0.05% |
| 2014 FY | 1.05 Billion CNY | 833.63% |
| 2014 Q4 | 1.05 Billion CNY | 17.88% |
| 2014 Q3 | 895 Million CNY | 71.46% |
| 2014 Q2 | 522 Million CNY | 362.17% |
| 2013 FY | 113 Million CNY | 1030.0% |
| 2013 Q2 | 35 Million CNY | 250.0% |
| 2013 Q3 | 14.5 Million CNY | -58.57% |
| 2013 Q1 | 10 Million CNY | 0.0% |
| 2013 Q4 | 113 Million CNY | 679.31% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q4 | 10 Million CNY | 0.0% |
| 2012 FY | 10 Million CNY | 0.0% |
| 2011 Q3 | - CNY | -100.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q2 | 3 Million CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q3 | - CNY | -100.0% |
| 2010 Q2 | 43 Million CNY | 0.0% |
| 2009 FY | 60.6 Million CNY | -3.81% |
| 2009 Q4 | 60.6 Million CNY | 0.0% |
| 2008 FY | 63 Million CNY | -26.32% |
| 2007 FY | 85.5 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 4.88 Billion CNY | 17.753% |
| ZJAMP Group Co., Ltd. | 2.88 Billion CNY | -39.186% |
| Luyan Pharma Co.,Ltd. | 4.84 Billion CNY | 16.975% |
| Ji Yao Holding Group Co., Ltd. | 1.44 Billion CNY | -177.443% |